Catechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors

Cancer

Volumn 117, Issue 7, 2011, Pages 1369-1376

  Small, Brent J ^a,b   Rawson, Kerri Sharp ^a   Walsh, Erin ^c   Jim, Heather S L ^b   Hughes, Tiffany F ^d   Iser, Lindsay ^a   Andrykowski, Michael A ^c   Jacobsen, Paul B ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

cancer survivor; cognitive performance; genetics; research methods

Indexed keywords

ANTHRACYCLINE; CATECHOL METHYLTRANSFERASE; CYCLOPHOSPHAMIDE; FLUOROURACIL; METHIONINE; METHOTREXATE; TAXANE DERIVATIVE; VALINE;

ALLELE; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; CANCER THERAPY; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CATECHOL O-METHYLTRANSFERASE; COGNITION DISORDERS; GENOTYPE; HUMANS; MIDDLE AGED; SURVIVORS;

EID: 79952834173     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25685     Document Type: Article

References (39)

1. Hewitt M, Greenfield SE., From Cancer Patient to Cancer Survivors. Lost in Translation. Washington, DC: National Academies Press; 2005.
2. Ahles T, Saykin A., Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer. 2007; 7: 192-201.
3. Correa DD, Ahles TA,. Cognitive adverse effects of chemotherapy in breast cancer patients. Curr Opin Support Palliat Care. 2007; 1: 57-62.
4. Jim HSL, Donovan KA, Small BJ, Andrykowski MA, Munster PN, Jacobsen PB., Cognitive functioning in breast cancer survivors: a controlled comparison. Cancer. 2009; 115: 1776-1783.
5. Anderson-Hanley C, Sherman ML, Riggs R, Agocha VB, Compas BE., Neuropsychological effects of treatment for adults with cancer: a meta-analysis and review of the literature. J Int Neuropsychol Soc. 2003; 9: 967-982. (Pubitemid 37428441)
6. Falleti MG, Sanfilippo A, Maruff P, Weih L, Phillips K-A., The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Brain Cognition. 2005; 59: 60-70. (Pubitemid 41405841)
7. Minisini A, Atalay G, Bottomley A, Puglisi F, Piccart M, Biganzoli L,. What is the effect of systemic anticancer treatment on cognitive function ? The Lancet Oncology. 2004; 5: 273-282. (Pubitemid 38541579)
8. Tannock IF, Ahles TA, Ganz PA, van Dam FS., Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol. 2004; 22: 2233-2239. (Pubitemid 41095159)
9. Vearncombe KJ, Rolfe M, Wright M, Pachana NA, Andrew B, Beadle G,. Predictors of cognitive decline after chemotherapy in breast cancer patients. J Int Neuropsychol Soc. 2009; 15: 951-962.
10. Ahles TA, Saykin AJ, Noll WW, et al. The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psychooncology. 2003; 12: 612-619. (Pubitemid 37086736)
11. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R., Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA. 1997; 278: 1349-1356. (Pubitemid 27449696)
12. Small BJ, Rosnick CB, Fratiglioni L, Bäckman L., Apolipoprotein E and cognitive performance: a meta-analysis. Psychol Aging. 2004; 19: 592-600. (Pubitemid 39603405)
13. Wisdom NM, Callahan JL, Hawkins KA., The effects of apolipoprotein E on non-impaired cognitive functioning: a meta-analysis. Neurobiol Aging. 2009 Mar 12. [Epub ahead of print].
14. Savitz J, Solms M, Ramesar R,. The molecular genetics of cognition: dopamine, COMT, and BDNF. Genes Brain and Behavior. 2006; 5: 311-328. (Pubitemid 43794814)
15. Goldberg TE, Weinberger DR., Genes and the parsing of cognitive processes. Trends Cog Sci. 2004; 8: 325-335. (Pubitemid 38887449)
16. Nagel IE, Chicherio C, Li SC, et al. Human aging magnifies genetic effects on executive functioning and working memory. Front Hum Neurosci. 2008; 2: 1.
17. Ferguson RJ, McDonald BC, Saykin AJ, Ahles TA., Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy. J Clin Oncol. 2007; 25: 3866-3870. (Pubitemid 47477262)
18. Silverman DHS, Dy CJ, Castellon SA, et al. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Res Treat. 2007; 103: 303-311. (Pubitemid 46944511)
19. Andrykowski MA, Burris JL, Walsh E, Small BJ, Jacobsen PB., Attitudes toward information about genetic risk for cognitive impairment after cancer chemotherapy: breast cancer survivors compared with healthy controls. J Clin Oncol. 2010; 28: 3442-3447.
20. Donovan KA, Small BJ, Andrykowski MA, Schmitt FA, Munster P, Jacobsen PB., Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma. Cancer. 2005; 104: 2499-2507. (Pubitemid 41691574)
21. Nelson HE,. The National Adult Reading Test (NART): Test Manual. Windsor, Berks, UK: NFER-Nelson; 1982.
22. Delis DC, Kramer JH, Kaplan E, Ober BA., California Verbal Learning Test: Adult Version. San Antonio, TX: Psychological Corporation; 1987.
23. Wechsler D., Weschler Memory Scale-III Manual. San Antonio, TX: Psychological Corporation; 1997.
24. Wechsler D., WAIS-III Administration and Scoring Manual. San Antonio, TX: Psychological Corporation; 1997.
25. D′Elia LF, Satz P, Uchiyama CL, White T., Color Trails Test. Odessa, FL: Psychological Assessment Resources; 1996.
26. Benton A, Hamsher K., Multilingual Aphasia Examination. Iowa City, IA: AJA Associates; 1989.
27. Reitan RM, Wolfson D., The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. Tucson, AZ: Neuropsychology Press; 1993.
28. Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA,. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma. Cancer. 2004; 100: 2292-2299.
29. Schagen SB, Muller MJ, Boogerd W, Mellenbergh GJ, van Dam FSAM., Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. J Natl Cancer Inst. 2006; 98: 1742-1745. (Pubitemid 44942713)
30. Schagen SB, Muller MJ, Boogerd W, et al. Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. Ann Oncol. 2002; 13: 1387-1397.
31. Schagen SB, van Dam FSAM, Muller MJ, Boogerd W, Lindeboom J, Bruning PF., Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer. 1999; 85: 640-650. (Pubitemid 29075285)
32. Holm S., A simple sequentially rejective multiple test procedure. Scand J Stat. 1979; 6: 65-70.
33. Wefel JS, Saleeba AK, Buzdar AU, Meyers CA., Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer. 2010; 116: 3348-3356.
34. Lee JJ, Swain SM., Peripheral neuropathy induced by microtubule- stabilizing agents. J Clin Oncol. 2006; 24: 1633-1642. (Pubitemid 46638788)
35. Ahles TA, Saykin AJ, Furstenberg CT, et al. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol. 2002; 20: 485-493. (Pubitemid 34072533)
36. Goldberg TE, Egan MF, Gscheidle T, et al. Executive subprocesses in working memory: Relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Arch Gen Psychiatry. 2003; 60: 889-896. (Pubitemid 37122307)
37. Barnett JH, Scoriels L, Munafà MR., Meta-analysis of the cognitive effects of the Catechol-O-methyltransferase gene Val158/108Met polymorphism. Biol Psychiatry. 2008; 64: 137-144.
38. Guttmacher AE, Collins FS,. Genetic medicine-a primer. New Engl J Med. 2002; 347: 1512-1520.
39. Hamburg MA, Collins FS., The path to personalized medicine. N Engl J Med. 2010; 363: 301-304.